Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology

American Journal of Transplantation

Volumn 14, Issue 1, 2014, Pages 193-201

  Sicard, A ^a,b   Amrouche, L ^a,b   Suberbielle, C ^c   Carmagnat, M ^c   Candon, S ^b,d   Thervet, E ^b,e   Delahousse, M ^f   Legendre, C ^a,b   Chatenoud, L ^b,d   Snanoudj, R ^a,b,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d INSERM   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f FOCH HOSPITAL   (France)

Author keywords

Anti HLA antibodies; antibody mediated rejection; desensitization protocol; donor specific antibodies

Indexed keywords

ALLOANTIBODY; BASILIXIMAB; CYCLOSPORIN; DONOR SPECIFIC ALLOANTIBODY; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPLEMENT DEPENDENT CYTOTOXICITY; DESENSITIZATION; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; MICROANGIOPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; VASCULITIS;

ANTI-HLA ANTIBODIES; ANTIBODY-MEDIATED REJECTION; DESENSITIZATION PROTOCOL; DONOR-SPECIFIC ANTIBODIES;

ADULT; DESENSITIZATION, IMMUNOLOGIC; GRAFT REJECTION; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84891026510     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12512     Document Type: Article

References (38)

1. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68-74.
2. Sellarés J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12: 388-399.
3. Loupy A, Hill GS, Jordan SC., The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol 2012; 8: 348-357.
4. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
5. Mengel M, Sis B, Haas M, et al. Banff 2011 Meeting report: New concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563-570.
6. Caro-Oleas JL, González-Escribano MF, Gentil-Govantes MÁ, et al. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation. Transplantation 2012; 94: 338-344.
7. Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008; 8: 324-331.
8. Mohan S, Palanisamy A, Tsapepas D, et al. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 2012; 23: 2061-2071.
9. Patel AM, Pancoska C, Mulgaonkar S, Weng FL., Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 2007; 7: 2371-2377.
10. Vlad G, Ho EK, Vasilescu ER, et al. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol 2009; 70: 589-594.
11. Couzi L, Araujo C, Guidicelli G, et al. Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay. Transplantation 2011; 91: 527-535.
12. Gupta A, Iveson V, Varagunam M, Bodger S, Sinnott P, Thuraisingham RC., Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: Are they relevant ? Transplantation 2008; 85: 1200-1204.
13. Higgins R, Lowe D, Hathaway M, et al. Human leukocyte antigen antibody-incompatible renal transplantation: Excellent medium-term outcomes with negative cytotoxic crossmatch. Transplantation 2011; 92: 900-906.
14. Verghese PS, Smith JM, McDonald RA, Schwartz SM, Nelson KA, Warner PR., Impaired graft survival in pediatric renal transplant recipients with donor-specific antibodies detected by solid-phase assays. Pediatr Transplant 2010; 14: 730-734.
15. Willicombe M, Brookes P, Santos-Nunez E, et al. Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 2011; 11: 470-477.
16. Lefaucheur C, Loupy A, Hill GS, et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010; 21: 1398-1406.
17. Collins ZV, Arnold PF, Peetoom F, Smith GS, Walford RL., A naturally occurring monospecific anti-HL-A8 isoantibody. Tissue Antigens 1972; 3: 358-363.
18. Tongio MM, Falkenrodt A, Mitsuishi Y, et al. Natural HLA antibodies. Tissue Antigens 1985; 26: 271-285.
19. Morales-Buenrostro LE, Terasaki PI, Marino-Vázquez LA, Lee J-H, El-Awar N, Alberú J., " Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008; 86: 1111-1115.
20. Ravindranath MH, Kaneku H, El-Awar N, Morales-Buenrostro LE, Terasaki PI., Antibodies to HLA-E in nonalloimmunized males: Pattern of HLA-IA reactivity of anti-HLA-E-positive sera. J Immunol 2010; 185: 1935-1948.
21. Hirata AA, McIntire FC, Terasaki PI, Mittal KK., Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation 1973; 15: 441-445.
22. Hirata AA, Terasaki PI., Cross-reactions between streptococcal M proteins and human transplantation antigens. Science 1970; 168: 1095-1096.
23. Raybourne RB, Bunning VK, Williams KM., Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigella species. Evidence for molecular mimicry in the spondyloarthropathies. J Immunol 1988; 140: 3489-3495.
24. Tsuchiya N, Husby G, Williams RC, Stieglitz H, Lipsky PE, Inman RD., Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid. J Clin Invest 1990; 86: 1193-1203.
25. Archer JR., Search for cross-reactivity between HLA B27 and Klebsiella pneumoniae. Ann Rheum Dis 1981; 40: 400-403.
26. Georgopoulos K, Dick WC, Goodacre JA, Pain RH., A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the etiology of ankylosing spondylitis. Clin Exp Immunol 1985; 62: 662-671.
27. Gross U, Chen JH, Kono DH, Yu DT., A ribosomal protein of Yersinia pseudotuberculosis having partial epitope identity with HLA-B27. Autoimmunity 1989; 7: 267-277.
28. Anglicheau D, Loupy A, Suberbielle C, et al. Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: A pilot study. Am J Transplant 2007; 7: 1185-1192.
29. Loupy A, Suberbielle-Boissel C, Zuber J, et al. Combined posttransplant prophylactic IVIg/anti-CD20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: A pilot study. Transplantation 2010; 89: 1403-1410.
30. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561-2570.
31. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
32. Reed EF, Rao P, Zhang Z, et al. Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant 2013; 13: 1859-1870.
33. El-Awar N, Terasaki PI, Nguyen A, et al. Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol 2009; 70: 844-853.
34. Haas M, Montgomery RA, Segev DL, et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007; 7: 576-585.
35. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124-2132.
36. Burns M, Cornell LD, Perry DK, et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008; 8: 2684-2694.
37. Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S., Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009; 87: 1681-1688.
38. Hirai T, Kohei N, Omoto K, Ishida H, Tanabe K., Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection. Transpl Int 2012; 25: 925-934.